Organization and Description of Business Operations (Details) - Subsequent Event [Member] - USD ($) |
1 Months Ended | |
|---|---|---|
Jul. 22, 2022 |
Jul. 19, 2022 |
|
| Organization and Description of Business Operations (Details) [Line Items] | ||
| Common stock, par value | $ 0.0001 | |
| Shares issued to underwriters (in Shares) | 1,250,000 | |
| Purchase price per share | $ 0.744 | |
| Offering price per share | $ 0.8 | |
| Net proceeds (in Dollars) | $ 855,000 | |
| Net of underwriter fees and commissions (in Dollars) | 70,000 | |
| Offering costs (in Dollars) | $ 75,000 | |
| Purchase of warrants for common stock (in Shares) | 62,500 | |
| Exercise price of warrant | $ 0.8 | |
| Over-Allotment Option [Member] | ||
| Organization and Description of Business Operations (Details) [Line Items] | ||
| Additional shares issued (in Shares) | 187,500 | |
| X | ||||||||||
- Definition Offering price per share. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Face amount per share of no-par value common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of excess stock shares of an entity that have been sold or granted to shareholders. No definition available.
|
| X | ||||||||||
- Definition Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|